47 research outputs found
Panel 7: otitis media:treatment and complications
Objective: We aimed to summarize key articles published between 2011 and 2015 on the treatment of (recurrent) acute otitis media, otitis media with effusion, tympanostomy tube otorrhea, chronic suppurative otitis media and complications of otitis media, and their implications for clinical practice. Data Sources: PubMed, Ovid Medline, the Cochrane Library, and Clinical Evidence (BMJ Publishing). Review Methods: All types of articles related to otitis media treatment and complications between June 2011 and March 2015 were identified. A total of 1122 potential related articles were reviewed by the panel members; 118 relevant articles were ultimately included in this summary. Conclusions: Recent literature and guidelines emphasize accurate diagnosis of acute otitis media and optimal management of ear pain. Watchful waiting is optional in mild to moderate acute otitis media; antibiotics do shorten symptoms and duration of middle ear effusion. The additive benefit of adenoidectomy to tympanostomy tubes in recurrent acute otitis media and otitis media with effusion is controversial and age dependent. Topical antibiotic is the treatment of choice in acute tube otorrhea. Symptomatic hearing loss due to persistent otitis media with effusion is best treated with tympanostomy tubes. Novel molecular and biomaterial treatments as adjuvants to surgical closure of eardrum perforations seem promising. There is insufficient evidence to support the use of complementary and alternative treatments. Implications for Practice: Emphasis on accurate diagnosis of otitis media, in its various forms, is important to reduce overdiagnosis, overtreatment, and antibiotic resistance. Children at risk for otitis media and its complications deserve special attention
Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison’s disease
S-Adenosyl-L-Methionine protects the probiotic yeast, Saccharomyces boulardii,from acid-induced cell death
Human milk mycobiota composition: relationship with gestational age, delivery mode, and birth weight
Intestinal and human milk microbiota studies during infancy have shown variations according to geographical location, delivery mode, gestational age, and mother-related factors during pregnancy. In this study, we performed metagenomic mycobiota analyses of 44 transient and mature human milk among five different groups: mothers of normal spontaneous delivery-term (NS-T), caesarean delivery-term (CS-T), premature (PT), small for gestational age (SGA), and large for gestational age (LGA) infants. Fungi were detected in 80 out of the 88 samples. Regarding the number of observed fungal species, the NS-T group was more homogeneous (less variable) comparing the other groups (P<0.05). In the transient human milk samples, the most abundant species were Saccharomyces cerevisiae (33.3%) and Aspergillus glaucus (27.4%). While A. glaucus (33.7%) was second most abundant species in mature milk, S. cerevisiae disappeared (P<0.01) and Penicillium rubens became the most abundant species (35.5%) (P<0.05). Among the NS-T group, the most abundant species was Malassezia globosa in both transient and mature milk. In contrast, S. cerevisiae was the most abundant species in transient human milk (45.0%) in the CS-T group, but it disappeared in mature milk (P<0.01). In transient milk, M. globosa was only represented 6.0-9.0% of taxa in the PT, SGA, and LGA groups (P<0.05). In transient and mature milk in the PT, SGA and LGA groups, the most abundant species were A. glaucus and P. rubens. In mature milk samples, P. rubens is more abundant in CS-T group, PT group and LGA group, than the NS-T groups (P<0.05 for all). Although fungi constitute only a very small part of the human milk microbiome, we observed some changes that the human milk mycobiota composition varies in caesarean delivery, premature, SGA and LGA groups, comparing the normal spontaneous delivery, as well as differences between transient and mature human milk.Peer reviewe
Quality-of-life evaluation of healthy siblings of children with chronic Illness
Background: Chronic disease of children can cause changes in the
health-related quality of life (HrQoL) of the family members.
Aims: To evaluate the HrQoL of healthy siblings of children with chronic
disease.
Study Design: Cross-sectional study.
Methods: The study included healthy sibling of children with chronic
disease (cerebral palsy, epilepsy; diabetes, celiac disease,
hematologic/ oncologic disease, or asthma) and healthy sibling of
healthy children to evaluate the quality of life. We used the Pediatric
Quality of Life Inventory questionnaire; the physical health and
psychosocial health scores were calculated using the responses of the
sibling and parent. The primary endpoint was the comparison of HrQoL
scores of healthy siblings of children with chronic disease and that of
healthy siblings of healthy children.
Results: This study included a respective healthy sibling of 191
children with chronic disease and healthy sibling of 100 healthy
children. The physical health, psychosocial health, and total health
scores of healthy siblings of children with chronic disease were
significantly lower than that of healthy siblings of healthy children
(p<0.001). Among the healthy siblings of children with chronic disease,
the lowest psychosocial health score was found in the siblings of
children with cerebral palsy, hematologic/oncologic disease. and asthma
(p<0.001). The global impact on the quality of life for healthy siblings
of children with chronic disease was significantly higher in the
self-report of the children than that of the parents (30.4\% versus
15.1\%, p<0.05).
Conclusion: Most healthy siblings of children with chronic disease are
physically and psychosocially affected and there is low parental
awareness of this condition. This can increase the risk of emotional
neglect and abuse of these children. Therefore. special support programs
are needed for the families of children with chronic diseases